Showing results (211-220 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|March 31, 2000
Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkagesP S Miller, R A Cassidy, T Hamma, et al.Pharmacology & Therapeutics|March 31, 2000
Transplatin-modified oligonucleotides as modulators of gene expressionM Giraud-Panis, M LengPharmacology & Therapeutics|March 31, 2000
Is irrelevant cleavage the price of antisense efficacy?C A SteinPharmacology & Therapeutics|March 31, 2000
Enantioselectivity of the antiviral effects of nucleoside analoguesJ ZemlickaPharmacology & Therapeutics|December 22, 1999
Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapyR Wolk, S M Cobbe, M N Hicks, et al.Pharmacology & Therapeutics|August 24, 1999
Substrate and inhibitor recognition of protein kinases: what is known about the catalytic subunit of phosphorylase kinase?D Graves, C Bartleson, A Biorn, et al.Pharmacology & Therapeutics|August 24, 1999
Strategies toward the design of novel and selective protein tyrosine kinase inhibitorsP Traxler, P FuretPharmacology & Therapeutics|August 24, 1999
Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitorsD W FryPharmacology & Therapeutics|August 24, 1999
Chemical approaches to the study of protein tyrosine kinases and their implications for mechanism and inhibitor designP A Cole, D Sondhi, K KimPharmacology & Therapeutics|August 24, 1999
The epidermal growth factor receptor and its inhibition in cancer therapyJ R WoodburnPageof 371